Pingzheng Mo

3.6k total citations · 2 hit papers
25 papers, 2.3k citations indexed

About

Pingzheng Mo is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Pingzheng Mo has authored 25 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 8 papers in Neurology and 8 papers in Epidemiology. Recurrent topics in Pingzheng Mo's work include COVID-19 Clinical Research Studies (11 papers), Long-Term Effects of COVID-19 (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Pingzheng Mo is often cited by papers focused on COVID-19 Clinical Research Studies (11 papers), Long-Term Effects of COVID-19 (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Pingzheng Mo collaborates with scholars based in China, United States and Sweden. Pingzheng Mo's co-authors include Yongxi Zhang, Yong Xiong, Liping Deng, Zhiyong Ma, Shihui Song, Qiu Zhao, Haizhou Wang, Fan Wang, Jiayan Nie and Ke Liang and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Pingzheng Mo

23 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia

2020 789 citations Haizhou Wang, Qiu Zhao et al. profile →
Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China

2020 653 citations Pingzheng Mo, Yuanyuan Xing et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pingzheng Mo China	13	1.8k	981	376	300	191	25	2.3k
Liping Deng China	13	1.6k 0.9×	924 0.9×	375 1.0×	385 1.3×	165 0.9×	50	2.2k
Mingqi Luo China	9	1.4k 0.8×	791 0.8×	462 1.2×	287 1.0×	133 0.7×	26	1.8k
Shihui Song China	7	1.5k 0.8×	868 0.9×	314 0.8×	209 0.7×	153 0.8×	16	1.8k
Qinyong Hu China	14	1.6k 0.9×	844 0.9×	502 1.3×	237 0.8×	182 1.0×	35	2.5k
Yongxi Zhang China	20	2.2k 1.2×	1.1k 1.1×	560 1.5×	460 1.5×	193 1.0×	56	3.0k
Dilek Azkur Türkiye	15	1.2k 0.7×	574 0.6×	240 0.6×	216 0.7×	136 0.7×	32	2.1k
Huaying Wang China	7	1.1k 0.6×	599 0.6×	285 0.8×	186 0.6×	174 0.9×	19	1.8k
Junqing Yue China	7	1.3k 0.7×	689 0.7×	383 1.0×	185 0.6×	196 1.0×	9	1.7k
Mi Mu China	8	1.4k 0.8×	762 0.8×	339 0.9×	205 0.7×	137 0.7×	10	2.0k

Countries citing papers authored by Pingzheng Mo

Since Specialization

Citations

This map shows the geographic impact of Pingzheng Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingzheng Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingzheng Mo more than expected).

Fields of papers citing papers by Pingzheng Mo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingzheng Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingzheng Mo. The network helps show where Pingzheng Mo may publish in the future.

Co-authorship network of co-authors of Pingzheng Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Pingzheng Mo. A scholar is included among the top collaborators of Pingzheng Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingzheng Mo. Pingzheng Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mo, Pingzheng, Rongrong Yang, Huifang Liu, et al.. (2025). Analysis of microorganisms and drug-resistance mutations detected by probe-capture metagenomics among HIV-infected patients with pneumonia. Frontiers in Microbiology. 16. 1616937–1616937.

Zhang, Zhongwei, Xue Hu, Pingzheng Mo, et al.. (2025). Clinical characteristics and outcomes of disseminated intravascular coagulation in patients with severe fever with thrombocytopenia syndrome. BMC Infectious Diseases. 25(1). 508–508. 1 indexed citations

Chen, Xiao‐Ping, Pingzheng Mo, Liangjun Chen, et al.. (2024). Diagnostic values of BALF metagenomic next-generation sequencing, BALF real-time PCR and serum BDG for Pneumocystis jirovecii pneumonia in HIV-infected patients. Frontiers in Microbiology. 15. 1421660–1421660. 3 indexed citations

Zhang, Zhongwei, Jie Liu, Xiaoping Chen, et al.. (2024). Rhabdomyolysis in Severe Fever With Thrombocytopenia Syndrome: Associations With Acute Kidney Injury and Mortality. Journal of Medical Virology. 96(12). e70095–e70095. 1 indexed citations

Xiong, Yu, Weicheng Liu, Xiaoping Chen, et al.. (2024). Survival of HIV associated diffuse large B-cell lymphoma and Burkitt lymphoma in China. Scientific Reports. 14(1). 30397–30397.

Xiong, Yu, Pingzheng Mo, Yajun Yan, et al.. (2023). The safety and efficacy of PD-1 inhibitors in patients with advanced cancers and HIV/AIDS in China. Frontiers in Oncology. 13. 1248790–1248790. 3 indexed citations

Deng, Liping, Qian Li, Wenjia Hu, et al.. (2023). Metagenomic next-generation sequencing versus traditional laboratory methods for the diagnosis of central nervous system opportunistic infections in HIV-infected Chinese adults. Scientific Reports. 13(1). 4921–4921. 2 indexed citations

Zhuang, Ke, Yongxi Zhang, Pingzheng Mo, et al.. (2022). Plasma proteomic analysis reveals altered protein abundances in HIV‐infected patients with or without non‐Hodgkin lymphoma. Journal of Medical Virology. 94(8). 3876–3889. 5 indexed citations

Guo, Wei, Yu Dong, Qian Zhang, et al.. (2022). Driving force of COVID-19 among people living with HIV in Wuhan, China. AIDS Care. 34(11). 1364–1371. 5 indexed citations

10.

Chen, Xiaoping, Qunqun Jiang, Zhiyong Ma, et al.. (2020). Clinical Characteristics of Hospitalized Patients with SARS-CoV-2 and Hepatitis B Virus Co-infection. Virologica Sinica. 35(6). 842–845. 71 indexed citations

11.

Zhong, Zibiao, Qiuyan Zhang, Haoyang Xia, et al.. (2020). Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients. American Journal of Transplantation. 20(7). 1916–1921. 87 indexed citations

12.

Song, Shihui, Tielong Chen, Liping Deng, et al.. (2020). Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China. Infectious Diseases of Poverty. 9(1). 82–82. 14 indexed citations

13.

Mo, Pingzheng, Liping Deng, Xiaoping Liu, et al.. (2020). Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study. Epidemiology and Infection. 148. e293–e293. 12 indexed citations

14.

Wang, Haizhou, Yongxi Zhang, Pingzheng Mo, et al.. (2020). Neutrophil to CD4+ lymphocyte ratio as a potential biomarker in predicting virus negative conversion time in COVID-19. International Immunopharmacology. 85. 106683–106683. 27 indexed citations

15.

Mo, Pingzheng, Liping Deng, Xiaoping Chen, Yong Xiong, & Yongxi Zhang. (2020). Rapid Progression of Kaposi’s sarcoma complicated with hemophagocytic syndrome in a severely immunosuppressed patient with HIV-infection: a case report. AIDS Research and Therapy. 17(1). 58–58. 2 indexed citations

16.

Guo, Wei, Yu Dong, Qian Zhang, et al.. (2020). A Survey for COVID-19 Among HIV/AIDS Patients in Two Districts of Wuhan, China. SSRN Electronic Journal. 65 indexed citations

17.

Mo, Pingzheng, Yuanyuan Xing, Yu Xiao, et al.. (2020). Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China. Clinical Infectious Diseases. 73(11). e4208–e4213. 653 indexed citations breakdown →

18.

Yu, Liang, Pingzheng Mo, Shu Li, et al.. (2015). Development and evaluation of a new interferon-gamma release assay for the diagnosis of tuberculosis infection in HIV-infected individuals in China. Infectious Diseases. 47(4). 237–243. 2 indexed citations

19.

Mo, Pingzheng, Qi Zhu, Rongrong Yang, et al.. (2014). Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus. International Journal of Infectious Diseases. 28. 95–100. 26 indexed citations

20.

Zhang, Jing, Yanqing Ye, Yong Wang, et al.. (2010). M. tuberculosis H37Rv Infection of Chinese Rhesus Macaques. Journal of Neuroimmune Pharmacology. 6(3). 362–370. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact